medigraphic.com

2023, Número 1

<< Anterior Siguiente >>

Rev Fac Med UNAM 2023; 66 (1)


Mielitis transversa aguda asociada con infección por SARS-CoV-2

Escobar PL, del Río QMA, Vaca L

Idioma: Español
Referencias bibliográficas: 62
Paginas: 8-23
Archivo PDF: 736.74 Kb.


RESUMEN

Además de provocar problemas respiratorios, la infección con el SARS-CoV-2 puede causar un espectro amplio de complicaciones neurológicas como son cefalea, ageusia, anosmia, encefalopatía, enfermedad cerebrovascular, síndrome de Guillain-Barré y otras polineuropatías, meningoencefalitis, encefalopatía hemorrágica necrotizante aguda y síndromes del sistema nervioso central asociados a inflamación. En esta revisión presentamos 39 casos de mielitis transversa aguda (MTA) asociados a infección por el SARS-CoV-2, confirmado por una prueba de reacción en cadena de la polimerasa (PCR) por hisopado nasofaríngeo y/o de antígeno en plasma. Los análisis bioquímicos de los pacientes confirmaron la ausencia de otros patógenos y de autoanticuerpos involucrados en inflamación del sistema nervioso, excepto por 2 casos, uno con autoanticuerpos contra la glicoproteína de la mielina de los oligodendrocitos (anti-MOG IgG) y otro con anti-MOG IgG y antidescarboxilasa del ácido glutámico (anti-GAD65), indicativos de una enfermedad autoinmune del sistema nervioso central. Los estudios de imagenología de resonancia magnética (RMN) confirmaron el diagnóstico de MTA. Aunque no se puede inferir causalidad, es muy probable que los casos aislados de MTA sean consecuencia de un proceso para o postinfeccioso en la COVID-19. La comprensión de los mecanismos que desencadenan estos trastornos neurológicos durante o al final de la infección viral, ayudarán a optimizar las estrategias terapéuticas para el manejo del paciente.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Escobar Pérez LI, Mártinez del Sobral-Sinitsyna S, delRío-Quiñones MA, Vaca L. Infección del sistema nerviosopor el coronavirus SARS-CoV-2. Rev. Fac. Med. (Méx). 2021;64,4:7-24. Disponible en: https://www.scielo.org.mx/scielo.php?pid=S0026-17422021000400007&script=sci_arttext

  2. Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, et al. A prospective study of neurologicaldisorders in hospitalized COVID-19 patients in New YorkCity. Neurology, 2021;96(4):e575-e586. Disponible en:https://n.neurology.org/content/96/4/e575

  3. Romoli M, Jelcic I, Bernard-Valnet R, García Azorín D,Mancinelli L, Akhvlediani T, et al. A systemic reviewof neurological manifestations of SARS-CoV-2 infection:the devil is hidden in the details. Eur J Neurol.2020:27(9):1712-1726. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/ene.14382

  4. Schulte EC, Hauer L, Kunz AB, Sellner J. Systematicreview of cases of acute myelitis in individuals withCOVID-19. Eur J Neurol. 2021;28:3230-3244. Disponibleen: https://onlinelibrary.wiley.com/doi/10.1111/ene.14952

  5. Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T,Meppiel E. Neurological manifestations associated withSARS-CoV-2 and other coronaviruses: A narrative reviewfor clinicians. Revue neurologique. 2021;177(1-2):51-

  6. Disponible en: https://www.em-consulte.com/article/1427757/alertePM6. Desforges M, Le Coupanec A, Brison E, Meessen-PinardM, Talbot PJ. Neuroinvasive and neurotropic humanrespiratory coronavirus: potential neurovirulentagents in humans. Adv Exp Med Biol. 2014;807:75-96. Disponible en: https://link.springer.com/chapter/10.1007/978-81-322-1777-0_6

  7. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD.Neurological associations of COVID-19. Lancet Neurol.2020;19(9):767-783. Disponible en: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30221-0/fulltext

  8. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potentialof SARS-CoV-2 may play a role in the respiratory failure ofCOVID-19 patients. J Med Virol. 2020;92(6):552-555. Disponibleen: https://onlinelibrary.wiley.com/doi/10.1002/jmv.25728

  9. De Seze J, Stojkovic T, Breteau G, Lucas C, Michon-PasturelU, Gauvrit JY, et al. Acute myelopathies: Clinical,laboratory and outcome profiles in 79 cases. Brain.2001;124(Pt 8):1509-1521. Disponible en: https://academic.oup.com/brain/article/124/8/1509/479947?login=false

  10. West TW, Hess C, Cree BAC. Acute transverse myelitis:demyelinating, inflammatory, and infectious myelopathies.Semin Neurol. 2012;32(2):97-113. Disponible en:https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1322586

  11. Altrocchi PH. Acute transverse myelopathy. Trans AmNeurol Assoc. 1963;88:186-188. Disponible en: https://pubmed.ncbi.nlm.nih.gov/14272214/

  12. Misra UK, Kalita J, Kumar S. A Clinical, MRI and neurophysiologicalstudy of acute transverse myelitis. J NeurolSci. 1996;138(1-2):150-156. Disponible en: https://www.jns-journal.com/article/0022-510X(95)00353-4/pdf

  13. López Chiriboga S, Flanagan EP. Myelitis and OtherAutoimmune Myelopathies. Continuum (MinneapMinn). 2021;27(1, Spinal Cord Disorders):62-92. Disponibleen: https://journals.lww.com/continuum/Abstract/2021/02000/Myelitis_and_Other_Autoimmune_Myelopathies.6.aspx

  14. Nejad Biglari H, Sinaei R, Pezeshki S, Khajeh Hasani F.Acute transverse myelitis of childhood due to novel coronavirusdisease 2019: The first pediatric case report andreview of literature. Iran J Child Neurol. 2021;15(1):107-112. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856438/

  15. Pourmoghaddas Z, Sadeghizadeh A, Tara SZ, ZandifarA, Rahimi H, Saleh R, et al. Longitudinally extensivetransverse myelitis as a sign of multisystem inflammatorysyndrome following COVID-19 infection: A pediatriccase report. J Neuroimmunol. 2021;360:577704. Disponibleen: https://www.jni-journal.com/article/S0165-5728(21)00231-9/fulltext

  16. Poyrazoğlu HG, Kırık S, Sarı MY, Esen I, Toraman ZA,Eroğlu Y. Acute demyelinating encephalomyelitis andtransverse myelitis in a child with COVID-19. Turk JPediatr. 2022;64(1):133-137. Disponible en: http://www.turkishjournalpediatrics.org/abstract.php?id=2408

  17. Advani S, Hosseini SMM, Zali A, Ommi D, Fatemi A,Khoshnoud RJ, et al. Transverse myelitis after SARSCoV-2 infection: Report of two cases with COVID-19.Clin Case Rep. 2021;9(12):e05196. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/ccr3.5196

  18. Ali L, Mohammed I, Zada Y, Salem H, Iqrar A.COVID-19-Associated Acute Transverse Myelitis: ACase Series of a Rare Neurologic Condition. Cureus.2021;13(10):e18551. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571429/

  19. Arslan D, Acar-Ozen P, Gocmen R, Elibol B, KarabudakR, Tuncer A. Post-COVID-19 longitudinally extensivetransverse myelitis: is it a new entity? Neurological Sciences.

  20. 2022;43(3):1569-1573. Disponible en: https://link.springer.com/article/10.1007/s10072-021-05640-120. Koc ER, Turan ÖF, Mengüç B. Covid-19 infection asa possible risk factor for longitudinally extensive transversemyelitis! Int J Neurosci. 2022;13:1-4. Disponibleen: https://www.tandfonline.com/doi/full/10.1080/00207454.2022.2098731

  21. Rifino N, Censori B, Agazzi E, Alimonti D, Bonito V,Camera G, et al. Neurologic manifestations in 1760COVID-19 patients admitted to Papa Giovanni XXIIIHospital, Bergamo, Italy. J Neurol.2021;268:2331-2338.Disponible en: https://link.springer.com/article/10.1007/s00415-020-10251-5

  22. Chow CCN, Magnussen J, Ip J, Su Y. Acute transversemyelitis in COVID-19 infection. BMJ Case Rep2020;13(8):e236720. Disponible en: https://casereports.bmj.com/content/13/8/e236720

  23. Munz M, Wessendorf S, Koretsis G, Tewald F, Baegi R,Krämer S, et al. Acute transverse myelitis after COVID-19pneumonia. J Neurol. 2020;267(8):2196-2197. Disponibleen: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250275/

  24. Yang E, Husein A, Martinez-Perez J, Li T. Post-COVID-19Longitudinally Extensive Transverse Myelitis with MyelinOligodendrocyte Glycoprotein Antibodies. Case RepNeurol Med. 2022;2022:1068227. Disponible en: https://www.hindawi.com/journals/crinm/2022/1068227/

  25. Shahali H, Ghasemi A, Farahani RH, Asl AN, HazratiE. Acute transverse myelitis after SARS-CoV-2 infection:a rare complicated case of rapid onset paraplegia. J Neurovirol.2021;27(2):354-358. Disponible en: https://link.springer.com/article/10.1007/s13365-021-00957-1

  26. Lu IF, Cornish JS, Ashok A, Chen SK, Athan E, HughesA. Early SARS-CoV-2-associated acute transverse myelitis:A case for neurotropism? J Intern Med. 2022;292(4):679-683. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/joim.13542

  27. Sarma DB, Bilello L. A case report of acute transversemyelitis following novel coronavirus infection. ClinPract Cases Emerg Med. 2020;4(3):321-323. Disponibleen: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434287/#:~:text=We%20present%20the%20case%20of,diagnosed%20with%20acute%20transverse%20myelitis.

  28. Alketbi R, AlNuaimi D, AlMulla M, AlTalai N, Samir M,Kumar N, et al. Acute myelitis as a neurological complicationof Covid-19: a case report and MRI findings. RadiolCase Re. 2020;15(9):1591-1595. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275163/

  29. Kilbertus S. Acute transverse myelitis attributed to SARSCoV-2 infection presenting as impaired mobility: a casereport. CJEM. 2021;23(4):551-552. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917167/

  30. Pandya C, Sangoi D, Badhe S. Low trauma posterior nativehip dislocation with acute longitudinal transverse myelitisdue to SARS-CoV-2. A case report. Trauma Case Rep.2021;34:100501. Disponible en: https://www.sciencedirect.com/science/article/pii/S2352644021001060?via%-3Dihub

  31. Börü ÜT, Bölük C, Toksoy CK, Demirbaş H. Acutecerebellitis, transverse myelitis and polyradiculoneuritisrelated to post-COVID-19 infection. J Spinal Cord Med.2022;45(5):765-768. Disponible en: https://www.tandfonline.com/doi/full/10.1080/10790268.2021.1969502

  32. Palahuta HV, Fartushna OY, Yevtushenko SK, Hnepa YY.Acute transverse myelitis as a neurological complicationof COVID-19: a case report. Wiad Lek. 2021;74(4):1045-1049. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34156028/

  33. Masuccio FG, Barra M, Claudio G, Claudio S. A rare caseof acute motor axonal neuropathy and myelitis relatedto SARS-CoV-2 infection. J Neurol. 2021;268(7):2327-2330. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497229/

  34. Zachariadis A, Tulbu A, Strambo D, Dumoulin A, DiVirgilio G. Transverse myelitis related to COVID-19infection. J Neurol. 2020;267(12):3459-3461. Disponibleen: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322383/

  35. Fonseca JP, Coelho A, Lourenço AC, Pires C, MargalhoP. Longitudinally extensive transverse myelitis (LETM)secondary to SARS-CoV-2 infection: A recent realityin spinal cord injury rehabilitation. Clin Case Rep.2022;10(5):e05876. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/ccr3.5876

  36. Doukas SG, Santos AP, Mir W, Daud S, Zivin-TutelaTH. A rare case of myelin oligodendrocyte glycoproteinantibody-associated transverse myelitis in a 40 year oldpatient with COVID-19. Cureus. 2022;14(4):e23877. Disponibleen: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074907/

  37. Moreno-Escobar MC, Kataria S, Khan E, Subedi R,Tandon M, Peshwe K, et al. Acute transverse myelitiswith dysautonomia following SARS-CoV-2 infection: Acase report and review of literature. J Neuroimmunol.2021;353:577523. Disponible en: https://www.jni-journal.com/article/S0165-5728(21)00050-3/fulltext

  38. Sotoca J, Rodríguez-Alvarez Y. COVID-19-associatedacute necrotizing myelitis. Neurol Neuroimmunol Neuroinflamm.2020;7(5):e803. Disponible en: https://nn.neurology.org/content/7/5/e803.long

  39. Dias da Costa M, Leal Rato M, Cruz D, Valadas A,Antunes AP, Albuquerque L. Longitudinally extensivetransverse myelitis with anti-myelin oligodendrocyte glycoproteinantibodies following SARS-CoV-2 infection. JNeuroimmunol. 2021;361:577739. Disponible en: https://www.jni-journal.com/article/S0165-5728(21)00266-6/fulltext

  40. Chakraborty U, Chandra A, Ray AK, Biswas P.COVID-19-associated acute transverse myelitis: a rare en-tity. BMJ Case Rep. 2020;13(8):e238668. Disponible en:https://casereports.bmj.com/content/13/8/e238668.long

  41. Durrani M, Kucharski K, Smith Z, Fien S. Acute transversemyelitis secondary to severe acute respiratorysyndrome coronavirus 2 (SARS-CoV-2): a case report.Clin Pract Cases Emerg Med. 2020;4(3):344-348. Disponibleen: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434243/

  42. Lee G. Acute longitudinal extensive transverse myelitissecondary to asymptomatic SARS-CoV-2 infection. BMJCase Rep. 2021;14(7):e244687. Disponible en: https://casereports.bmj.com/content/14/7/e244687.long

  43. Prete S, McShannic JD, Fertel BS, Simon EL. Acute transversemyelitis progressing to permanent quadriplegia followingCOVID-19 infection. Am J Emerg Med. 2022;56:391.e1-391.e3. Disponible en: https://www.sciencedirect.com/science/article/pii/S0735675722001231?via%3Dihub

  44. Ahmad SA, Salih KH, Ahmed SF, Kakamad FH,Salh AM, Hassan MN, et al. Post COVID-19 transversemyelitis; a case report with review of literature.Ann Med Surg (Lond). 2021;69:102749. Disponibleen: https://www.sciencedirect.com/science/article/pii/S2049080121006993?via%3Dihub

  45. Valiuddin H, Skwirsk B, Paz-Arabo P. Acute transversemyelitis associated with SARS-CoV-2: a case report.Brain Behav Immun Health. 2020;5:100091. Disponibleen: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275168/

  46. Kara S, Candelore T, Youssef P, Nedd K. Evidence of post-COVID-19 transverse myelitis demyelination. Cureus.2021;13(10):e19087. Disponible en: https://www.cureus.com/articles/68956-evidence-of-post-covid-19-transverse-myelitis-demyelination

  47. Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. Acute myelitisafter SARS-CoV-2 infection: a case report. medRxiv.2020. Disponible en: https://www.medrxiv.org/content/10.1101/2020.03.16.20035105v2.full-text

  48. Sellner J, Hemmer B, Muhlau M. The clinical spectrumand immunobiology of parainfectious neuromyelitis optica(Devic) syndromes. J Autoimmun. 2010;34(4):371-379.Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0896841109001279?via%3Dihub

  49. Beh SC, Greenberg BM, Frohman T, Frohman EM.Transverse myelitis. Neurol Clin. 2013;31(1):79-138.Disponible en: https://www.sciencedirect.com/science/article/pii/S0733861912000692?via%3Dihub

  50. Berman M, Feldman S, Alter M, Zilber N, Kahana E.Acute transverse myelitis: incidence and etiologic considerations.Neurology. 1981;31(8):966-971. Disponible en:https://pubmed.ncbi.nlm.nih.gov/7196523/

  51. Borchers AT, Gershwin ME. Transverse myelitis. AutoimmunRev. 2012;11(3):231-248. Disponible en:https://www.sciencedirect.com/science/article/abs/pii/S1568997211001200?via%3Dihub

  52. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologicmanifestations of hospitalized patients with coronavirusdisease 2019 in Wuhan, China. JAMA Neurol.2020;77(6):683-690. Disponible en: https://jamanetwork.com/journals/jamaneurology/fullarticle/2764549

  53. Natoli S, Oliveira V, Calabresi P, Maia LF, Pisani A. DoesSARS-CoV-2 invade the brain? Translational lessons fromanimal models. Eur J Neurol. 2020;27(9):1764-1773. Disponibleen: https://onlinelibrary.wiley.com/doi/10.1111/ene.14277

  54. Nemoto W, Yamagata R, Nakagawasai O, Nakagawa K,Hung WY, et al. Effect of spinal angiotensin-convertingenzyme 2 activation on the formalin-induced nociceptiveresponse in mice. Eur J Pharmacol. 2020;872:172950.Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S001429992030042X?via%3Dihub

  55. Kremer S, Lersy F, Anheim M, Merdji H, Schenck M,Oesterlé H, et al. Neurologic and neuroimaging findingsin patients with COVID-19: a retrospective multicenterstudy. Neurology. 2020;95(13):e1868-e1882. Disponibleen: https://n.neurology.org/content/95/13/e1868.long

  56. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H,Takamino J, et al. A first case of meningitis/encephalitisassociated with SARS-Coronavirus-2. Int J Infect Dis.2020;94;55-58. Disponible en: https://www.ijidonline.com/article/S1201-9712(20)30195-8/fulltext

  57. Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, ReidyJ, Lednicky J, et al. Central nervous system involvement bysevere acute respiratory syndrome coronavirus-2 (SARSCoV-2). J Med Virol. 2020;92(7):699-702. Disponibleen: https://onlinelibrary.wiley.com/doi/10.1002/jmv.25915

  58. Virhammar J, Kumlien E, Fällmar D, Frithiof R, JackmannS, Sköld MK, et al. Acute necrotizing encephalopathywith SARS-CoV-2 RNA confirmed in cerebrospinalfluid. Neurology. 2020;95(10):445-449. Disponible en:https://n.neurology.org/content/95/10/445.long

  59. Kansagra SM, Gallentine WB. Cytokine storm ofacute necrotizing encephalopathy. Pediatr Neurol.2011;45(6):400-402. Disponible en: https://www.pedneur.com/article/S0887-8994(11)00383-3/fulltext

  60. Filosto M, Cotti Piccinelli S, Gazzina S, Foresti C, FrigeniB, Servalli MC, et al. Guillain-Barre syndrome andCOVID-19: an observational multicenter study from twoItalian hotspot regions. J Neurol Neurosurg Psychiatry.2021;92(7):751-756. Disponible en: https://jnnp.bmj.com/content/92/7/751.long

  61. Abdelhady M, Elsotouhy A, Vattoth S. Acute flaccid myelitisin COVID-19. BJR Case Rep. 2020;6(3):20200098. Disponibleen: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465751/

  62. Kincaid O, Lipton HL. Viral myelitis: an update. CurrNeurol Neurosci Rep. 2006:6(6):469-474. Disponibleen: https://link.springer.com/article/10.1007/s11910-006-0048-1




2020     |     www.medigraphic.com